Strategic Acquisition RespirTech was acquired by Philips in 2017, strengthening its market position in respiratory care and providing opportunities to leverage Philips’ extensive distribution channels and technological resources to expand sales in hospital and home settings.

Innovative Product Portfolio The company offers advanced airway clearance therapies such as the Philips InCourage system and Philips Respironics CoughAssist T70, which can be promoted to healthcare providers and caregivers looking for effective solutions for chronic respiratory conditions.

Market Focus RespirTech operates within the respiratory medical equipment sector with a revenue range of $25 million to $50 million, presenting potential cross-selling opportunities to related healthcare providers and institutions currently utilizing or seeking respiratory therapy devices.

Digital Engagement The company's use of digital marketing tools like Amazon Advertising and Facebook suggests an active approach to reaching healthcare professionals and consumers online, offering avenues for targeted campaigns to increase product adoption.

Industry Presence With a relatively small but specialized team of up to 200 employees and a focus on chronic respiratory care, RespirTech is likely open to partnerships and collaborations with suppliers, service providers, or healthcare distributors to enhance product reach and market penetration.